Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 μg in the treatment of seasonal allergic rhinitis

Allergy and Asthma Proceedings

Volumn 30, Issue 3, 2009, Pages 255-262

  Kaliner, Michael A ^a   Storms, William ^b   Tilles, Stephen ^c   Spector, Sheldon ^d   Tan, Ricardo ^d   LaForce, Craig ^e   Lanier, Bobby Q ^f   Chipps, Bradley ^g  

^a Institute for Asthma and Allergy   (United States)

^b William Storms Allergy Clinic   (United States)

^c Asthma Inc   (United States)

^d California Allergy and Asthma Medical Group   (United States)

^e Carolina Allergy and Asthma Consultants   (United States)

^f North Texas Institute for Clinical Trials   (United States)

^g Capital Allergy and Respiratory Disease Center   (United States)

Author keywords

Allergic conjunctivitis; Allergic rhinitis; Allergy; Antihistamines; Fluticasone; Intranasal steroids; Nasal antihistamines; Olopatadine; Seasonal allergic rhinitis

Indexed keywords

FLUTICASONE PROPIONATE; OLOPATADINE; ANDROSTANE DERIVATIVE; ANTIALLERGIC AGENT; DIBENZOXEPIN DERIVATIVE; FLUTICASONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EPISTAXIS; EYE DISEASE; FEMALE; HAY FEVER; HUMAN; LIVER CONGESTION; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SNEEZING; SOMNOLENCE; SORE THROAT; TASTE DISCRIMINATION; COMPARATIVE STUDY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; CHILD; DIBENZOXEPINS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

EID: 68249157077     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2009.30.3232     Document Type: Article

References (23)

1. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol 122:S1-S84, 2008.
2. Marple BF, Fornadley JA, Patel AA, et al. Keys to successful management of patients with allergic rhinitis: Focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg 136:S107-S124, 2007.
3. Asthma and Allergy Foundation of America (AAFA). Consumer survey, 2005. Available online at www.aafa.org; last accessed May 2008.
4. 2LEN and AllerGen). Allergy 63:S8-S160, 2008.
5. Settipane RA. Rhinitis: A dose of epidemiological reality. Allergy Asthma Proc 24:147-154, 2003.
6. Kaliner MA. A novel and effective approach to treating rhinitis with nasal antihistamines. Ann Allergy Asthma Immunol 99:383-391, 2007.
7. Berger WE. Once-daily olopatadine ophthalmic solution 0.2% in the treatment of allergic conjunctivitis and rhinoconjunctivitis. Expert Rev Pharmacoecon Outcomes Res 7:221-226, 2007.
8. Patel D, Garadi R, Burbaker M, et al. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: Olopatadine hydrochloride versus mometasone furoate monohydrate. Allergy Asthma Proc 28:592-599, 2007.
9. Meltzer EO, Hampel FC, Ratner PH, et al. Safety and efficacy of olopatadine hydrochloride spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 95:600-606, 2005.
10. Ratner PH, Hampel FC, Amar N, et al. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar. Ann Allergy Asthma Immunol 95:474-479, 2005.
11. Fairchild CJ, Meltzer EO, Roland PS, et al. Comprehensive report of the efficacy, safety, quality of life, and work impact of olopatadine 0.6% and olopatadine 0.4% treatment in patients with seasonal allergic rhinitis. Allergy Asthma Proc 28:1-8, 2007.
12. Hampel FC, Ratner PH, Amar NJ, et al. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine 0.6% compared with vehicle placebo. Allergy Asthma Proc 27:202-207, 2006.
13. Berkowitz RB, Bernstein DI, LaForce C, et al. Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis. Allergy 54:64-69, 1999.
14. Lumry WR. A review of the preclinical and clinical data of newer intranasal steroid use in the treatment of allergic rhinitis. J Allergy Clin Immunol 104:S150-S158, 1999.
15. Selner JC, Weber RW, Richmond GW, et al. Onset of action of aqueous beclomethasone dipropionate nasal spray in seasonal allergic rhinitis. Clin Ther 17:1099-1109, 1999.
16. Day JH, Briscoe MP, Rafeiro E, et al. Onset of action of intranasal budesonide (Rhinocort Aqua) in seasonal allergy rhinitis studied in a controlled exposure model. J Allergy Clin Immunol 105:489-494, 2000.
17. Day JH, Buckeridge DL, Clark RH, et al. A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis. J Allergy Clin Immunol 97:1050-1057, 1996.
18. Bernstein DI, Creticos PS, Busse WW, et al. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol 97:749-755, 2003.
19. Martin BG, Andrews CP, van Bavel JH, et al. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Ann Allergy Asthma Immunol 96:851-857, 2006.
20. Ratner PH, Howland WC III, Arastu R, et al. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Ann Allergy Asthma Immunol 90:536-542, 2003.
21. Tinkelman D, Falliers C, Gross G, et al. Multicenter evaluation of triamcinolone acetonide nasal aerosol in the treatment of adult patients with seasonal allergic rhinitis. Ann Allergy 64:234-239, 1990.
22. Bjerrum P, and Illum P. Treatment of seasonal allergic rhinitis with budesonide and disodium cromoglycate. Allergy 40:65-69, 1985.
23. Kaiser HB, Naclerio RM, Given J, et al. Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhintis. J Allergy Clin Immunol 119:1430-1437, 2007.